To c-06: preparation of 400 grams of non-GMP antibiotic candidate FG-960-2
Ended Awarded Last action
- Contract number
- 75N93019F00133
- Awardee
-
Curia Global Inc. UEI ELCNZCS8GEA3
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $610,341
Award facts
- Opportunity
-
- NIHAI2017090 Solicitation number
- Nonclinical Services for Development of Interventional Agents for Infectious Diseases Award Notice · Posted Feb 13, 2017
- Contract value 100% obligated
- $610,340.86 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albany, NY 12212, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$179,305 | |
| Original award | $789,646 |
About this award
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Curia Global Inc. (doing business as Amri), a for-profit organization and manufacturer of goods. The award, valued at $610,340.86, is a delivery order under the Nonclinical Services for Development of Interventional Agents indefinite-delivery, indefinite-quantity (IDIQ) contract. The contract directs Curia to prepare 400 grams of non-GMP (good manufacturing practice) antibiotic candidate FG-960-2. This award does not have a set-aside designation. Curia is a leading global contract development and manufacturing organization (CDMO) that has provided extensive pharmaceutical research and development support services to various federal agencies, including NIAID, through prime and subcontract awards.
Quick answers
Who was awarded contract 75N93019F00133?
75N93019F00133 was awarded to Curia Global Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 20, 2019.
How much is contract 75N93019F00133 worth?
The government has obligated $610,341 on 75N93019F00133.
Is contract 75N93019F00133 an order under another contract?
Yes. 75N93019F00133 is a delivery order under 75N93018D00008, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93019F00133 competed?
The extent of competition for 75N93019F00133 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award